Cristal Therapeutics is a pharmaceutical company developing superior products based on its proprietary CriPec® platform. Cristal Therapeutics’ mission is to improve the therapeutic performance of drugs resulting in commercial opportunities in various disease areas. The application of CriPec® potentially results in a better efficacy and enhanced tolerability due to an improved disposition. The first product that is independently being developed by Cristal Therapeutics is CriPec® docetaxel for the treatment of solid tumours. The company is founded in April 2011 and based in Maastricht, The Netherlands
View Top Employees from Cristal TherapeuticsWebsite | http://www.cristaltherapeutics.com |
Revenue | $1 million |
Funding | $48.8 million |
Employees | 13 (3 on RocketReach) |
Founded | 2011 |
Address | Oxfordlaan 55, Maastricht, Limburg, NL |
Phone | +31 43 388 5868 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Business Services General, Medical, Pharmaceuticals, Business Services, Health Care, Nanotechnology, Pharmaceutical, Therapeutics |
Web Rank | 12 Million |
Keywords | Cristal Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Cristal Therapeutics employee's phone or email?
The Cristal Therapeutics annual revenue was $1 million in 2024.
3 people are employed at Cristal Therapeutics.
Cristal Therapeutics is based in Maastricht, Limburg.
The NAICS codes for Cristal Therapeutics are [32, 3254, 32541, 325].
The SIC codes for Cristal Therapeutics are [283, 28].